Recent Quotes (30 days)

You have no recent quotes
chg | %

Shire PLC news

   Watch this stock
Showing stories 1 - 10 of about 102   

Articles published

SHP 4,292.54 -56.46 (-1.30%)
price chart
Why AstraZeneca plc and Shire plc are 2 growth stars
And pharmaceutical companies AstraZeneca (LSE: AZN) and Shire (LSE: SHP) are two of the leading exponents in Britain.
Shire plc (NASDAQ:SHPG) Focus on Ratings
Covering Street analysts have a current average rating of 1.25 on shares of Shire plc (NASDAQ:SHPG). 11 analysts polled by Zacks Research are used in this consensus rating.
Price Target Review on : Shire plc (NASDAQ:SHPG)  The Post
JP Morgan Maintains Shire PLC (ADR) to Overweight with Price Target $239.00
Brokerage firm JP Morgan Maintains its rating on Shire PLC (ADR)(NASDAQ:SHPG). In a research note issued to the investors, the brokerage major Raises the price-target to $239.00 per share.
Shire PLC (ADR) 19.4% Potential Upside Now Implied by Stifel  DirectorsTalk Interviews
Analysts Suggestion Alert: Shire plc (NASDAQ:SHPG) , Mylan N.V. (NASDAQ:MYL)  Street Updates
You could beat the market with GlaxoSmithKline plc and Shire plc
GlaxoSmithKline (LSE: GSK) and Shire (LSE: SHP) are two such companies. Shire is a world-leading producer of rare disease treatments, and the company is unlikely to be displaced from this position anytime soon.
Blue Jay Capital Management LLC Decreased Stake in Shire Plc (NASDAQ:SHPG) by ...
Andrew Feldstein decreased its stake in Shire Plc (NASDAQ:SHPG) by 50.94% based on its latest 2016Q1 regulatory filing with the SEC.
Could National Grid plc and Shire plc really make you rich?
Pharmaceuticals group Shire last week announced its first quarter results for the three months to 31 March. The FTSE 100 drug maker reported a rise in pre-tax profit to $491.7m, compared to $471.3m for Q1 2015, with total revenue rising from $1.49bn to ...
Glg Partners LP Increased Shire Plc (Call) (NASDAQ:SHPG) by $13.31 Million as ...
Noam Gottesman increased its stake in Shire Plc (Call) (NASDAQ:SHPG) by 31.1% based on its latest 2016Q1 regulatory filing with the SEC.
Will Midatech Pharma plc be the next Shire plc?
Specialist pharmaceutical company Midatech Pharma (LSE: MTPH) is a firm with big ambitions. The company's chief executive, Dr Jim Phillips, declared in a recent investor presentation that Midatech aims to be another growth success story like London ...
Shire PLC 27.4% Potential Upside Indicated by HSBC
Shire PLC using EPIC/TICKER code LON:SHP has had its stock rating noted as 'Retains' with the recommendation being set at 'BUY' today by analysts at HSBC.
Weekly Investment Analysts' Ratings Changes for Shire PLC (SHP)  Web Breaking News
Shire PLC (LON:SHP) Issued With 'Overweight' Rating From JP Morgan ...  Share Trading News
Shire PLC 34.6% Potential Upside Indicated by JP Morgan Cazenove
Shire PLC using EPIC/TICKER code LON:SHP had its stock rating noted as 'Reiterates' with the recommendation being set at 'OVERWEIGHT' this morning by analysts at JP Morgan Cazenove.
Shire PLC Stock Price Increases Today  Franklin Independent
Shire PLC (LON:SHP) Issued With 'Overweight' Rating At JP Morgan  FTSE News